Cargando…
Bacillus Calmette–Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study
BACKGROUND: Cutaneous warts present a therapeutic challenge because of recurrence and multiplicity and may become a frustrating condition for both patients and physicians. In the past few years, there has been an increase in intralesional immunotherapy for recurrent multiple warts not only because o...
Autores principales: | Jaisinghani, Avtar Kishan, Dey, Vivek Kumar, Suresh, M S, Saxena, Animesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440180/ https://www.ncbi.nlm.nih.gov/pubmed/30983619 http://dx.doi.org/10.4103/ijd.IJD_558_16 |
Ejemplares similares
-
Bacillus Calmette–Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2021) -
The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy
por: Gupta, Sunil Kumar
Publicado: (2020) -
Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021) -
Excellent Response to Intralesional Bacillus Calmette-Guérin Vaccine in a Recalcitrant Periungual Wart
por: Kumar, Piyush, et al.
Publicado: (2014) -
The Bacillus Calmette-Guérin (BCG) Vaccine: Is it a better choice for the treatment of viral warts?
por: Al-Yassen, Asaad Q., et al.
Publicado: (2020)